Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

MLA

Prerna Arora, et al. “Neutralisation Sensitivity of the SARS-CoV-2 XBB.1 Lineage.” The Lancet. Infectious Diseases, Nov. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7dddddb920a2e82a19faf51166edead8&authtype=sso&custid=ns315887.

APA

Prerna Arora, Anne Cossmann, Sebastian R Schulz, Gema Morillas Ramos, Metodi V Stankov, Hans-Martin Jäck, Georg M N Behrens, Stefan Pöhlmann, & Markus Hoffmann. (2022). Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage. The Lancet. Infectious Diseases.

Chicago

Prerna Arora, Anne Cossmann, Sebastian R Schulz, Gema Morillas Ramos, Metodi V Stankov, Hans-Martin Jäck, Georg M N Behrens, Stefan Pöhlmann, and Markus Hoffmann. 2022. “Neutralisation Sensitivity of the SARS-CoV-2 XBB.1 Lineage.” The Lancet. Infectious Diseases, November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7dddddb920a2e82a19faf51166edead8&authtype=sso&custid=ns315887.